Antipsychotic Prescribing at AAPP 2027 Annual Meeting
4 sessions on antipsychotic prescribing · April 4–7, 2027, Louisville, KY. Compare antipsychotic prescribing at other meetings →
Sunday, April 4
14:40–15:40 · Debate
Choices, Choices: A Debate on Antipsychotic Polypharmacy Care Decisions
Bob Haight · Amy Werremeyer · Austin Campbell
A debate-format session on contentious antipsychotic decisions where guidelines give limited direction, including polypharmacy versus clozapine monotherapy, choosing among long-acting injectables, and handling inadequate response to LAIs.
Clozapine · Deprescribing & Polypharmacy · Long-Acting Injectables
Monday, April 5
12:20–13:20 · Lecture · Clinical Application Series
Medication Strategies for Behavioral and Psychological Symptoms of Dementia
Reviews how behavioral and psychological symptoms of dementia present and weighs the evidence, benefits and risks of current and newly approved medications, including for Parkinson disease psychosis. Focuses on building individualized treatment plans.
14:50–15:50 · Lecture · Member-Submitted Program
Antipsychotic Pharmacogenomics: Consensus Guideline Updates and Clinical Application
Reviews current consensus guidelines on pharmacogenomic testing for antipsychotic therapy, key gene-drug interactions, and which patients may benefit most. Uses real-world clinical scenarios to show how to apply results to treatment decisions.
Pharmacogenomics & Precision Psychiatry · Schizophrenia & Psychosis
Tuesday, April 6
09:15–10:15 · Lecture · Clinical Application Series
Psychosis in the Context of Substance Use: Primary Diagnosis or Substance Effect?
Aaron Salwan · Abraham Thengampallil
Online course on telling substance-induced psychosis apart from a primary psychotic disorder. Covers substances linked to psychosis, treatment approaches including antipsychotic management, and the psychiatric pharmacist's role.
Measurement-Based Care & Diagnosis · Schizophrenia & Psychosis · Substance Use Disorders
Other topics at this meeting
Drug Interactions & Safety 5Practice, Policy & Workforce 5Medical Comorbidity & C-L Psychiatry 5Anxiety Disorders 4Collaborative & Integrated Care 4Education & Training 4Schizophrenia & Psychosis 4Deprescribing & Polypharmacy 3Depression 3Measurement-Based Care & Diagnosis 3Pharmacogenomics & Precision Psychiatry 3Child & Adolescent 2